The FDA Biomarker Qualification Program approved changes in hip bone mineral density (BMD) after treatment to serve as a surrogate endpoint in place of bone fractures in anti-osteoporosis drug ...
The 2016 Warwick Agreement on femoroacetabular impingement (FAI) syndrome was convened to build an international, multidisciplinary consensus on the diagnosis and management of patients with FAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback